The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 01, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raksha Sudhir Valia, a person acting in concert (promoter group member) holding 2,88,30,352 shares (1.20% stake) in Sun Pharma, has disclosed creation of three new pledges covering 14,60,000 equity shares (about 0.06% of total share capital). The pledges were created on March 27-28, 2025, with 4,00,000 and 5,60,000 shares pledged in favor of Aditya Birla Finance Ltd, and 5,00,000 shares pledged in favor of Tata Capital Ltd, all as security for loans availed by a third party. After these events, her total encumbered shares have risen from 99,05,400 to 1,13,65,400 shares, representing 0.47% of Sun Pharma's total share capital. The pledges are for third-party borrowings, not for company-level financing.
The pledges are small in size relative to Sun Pharma's total share capital and are against third-party loans, not company borrowing. Raksha Valia's encumbered shares now stand at about 39% of her personal holding, well below the 50% threshold that typically raises concern. Investors are unlikely to see any material impact on the stock from this disclosure.